Cvs Pharmacy #02779 is an authorized DME supplier for medicare equipments and products.
Cvs Pharmacy #02779 is a Pharmacy in Annapolis, Maryland. This pharmacy is owned and operated by Maryland Cvs Pharmacy Llc. It is located at 503 S Cherry Grove Ave, Annapolis and it's customer support contact number is 443-482-3981. The authorized person of Cvs Pharmacy #02779 is Susan Colbert who is Director, Payer Relations of the pharmacy and his contact number is 401-770-2751. Active license number of Cvs Pharmacy #02779 is P03063 for Pharmacy in Maryland. Cvs Pharmacy #02779 accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance. Cvs Pharmacy #02779 is a facility used by pharmacists for the compounding and dispensing of medicinal preparations and other associated professional and administrative services. A pharmacy is a facility whose primary function is to store, prepare and legally dispense prescription drugs under the professional supervision of a licensed pharmacist. It meets any licensing or certification standards set forth by the jurisdiction where it is located.
Pharmacy Details:
Cvs Pharmacy #02779 type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
Cvs Pharmacy #02779
Type:
Pharmacy
Location:
503 S Cherry Grove Ave, Annapolis, Maryland, 21401-4244
Phone:
443-482-3981
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
Susan Colbert
Position:
Director, Payer Relations
Contact Number:
401-770-2751
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1396849246
NPI Enumeration Date:
12 Sep, 2006
NPI Last Update On:
16 Feb, 2011
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Cvs Pharmacy #02779 are as mentioned below.
Specialization
License Number
State
Status
Pharmacy
P03063
Maryland
Primary
Durable Medical Equipment & Medical Supplies
Secondary
Community/Retail Pharmacy
Secondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
570072800 - RX
Medicaid
Maryland
2126553
Other
Other Id Number-commercial Number
Medicare Enrollment:
Cvs Pharmacy #02779 is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID:
Enrollment ID:
Org Name
Medicare Entity Type
7719033703
O20100930009854
Maryland Cvs Pharmacy Llc
DME SUPPLIER - PHARMACY
Products Available:
Cvs Pharmacy #02779 has following products available for sale under medicare.
Products
Blood Glucose Monitors & Supplies: Mail Order
Blood Glucose Monitors & Supplies: Non-mail Order
Canes & Crutches
Commodes, Urinals, & Bedpans
Enteral Equipment And/or Supplies
Enteral Nutrients
Heat & Cold Applications
Nebulizer Equipment & Supplies
Ostomy Supplies
Parenteral Equipment And/or Supplies
Parenteral Nutrients
Surgical Dressings
Urological Supplies
Walkers
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1 Cvs Dr, Po Box 1075 Woonsocket, Rhode Island
Zip:
02895-6146
Phone Number:
401-765-1500
Fax Number:
401-770-7108
Patients can reach Cvs Pharmacy #02779 at 503 S Cherry Grove Ave, Annapolis, Maryland or can call on customer care at 443-482-3981.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.